Diabetes: Medical Equipment

(asked on 23rd April 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how he plans to fund prescriptions for Continuous Glucose Monitoring devices following their addition to the high-cost tariff-excluded devices list for 2019-20.


Answered by
Seema Kennedy Portrait
Seema Kennedy
This question was answered on 1st May 2019

The information requested on the number of prescriptions that have been issued for continuous glucose monitoring devices in each clinical commissioning group (CCG) area in not collected. CCGs are responsible for commissioning and funding diabetes services, including funding for prescriptions for continuous glucose monitoring devices, for their local populations. CCGs are clinically led organisations that have both the local knowledge and accountability to make commissioning and funding decisions in the best interests of their patients.

CCGs and providers should agree a local price for when these devices are in use, as they are not set by the national tariff but are in the high cost devices list in the tariff for 2019/20.

Reticulating Splines